期刊文献+

早中期慢性肾脏病患者颈动脉内中膜增厚及粥样斑块的危险因素研究 被引量:3

Influential Factors of Carotid Arteries Atheromatous Plaques and Intima-media Thickness in Patients with Chronic Kidney Disease
下载PDF
导出
摘要 目的探讨1~4期慢性肾脏病(CKD)患者发生颈动脉内中膜厚度(IMT)增厚及颈动脉粥样斑块的危险因素。方法回顾性分析新疆医科大学第一附属医院217例CKD 1~4期患者的临床资料,分析其IMT增厚、颈动脉粥样斑块发生的危险因素。结果单因素相关分析显示,颈动脉IMT增厚与年龄、收缩压、纤维蛋白原、空腹血糖、血尿酸及血清磷呈正相关,而与肾小球滤过率呈负相关;颈动脉斑块与年龄、纤维蛋白原、空腹血糖、血尿酸及血清磷呈正相关,而与肾小球滤过率呈负相关。多因素逐步回归提示,颈动脉IMT增厚与CKD分级、血尿酸分级、纤维蛋白原分级、年龄分级、收缩压分级相关;颈动脉斑块与CKD分级、纤维蛋白原分级、年龄分级相关。结论肾小球滤过率、血尿酸、纤维蛋白原、收缩压、年龄是早中期CKD患者发生动脉粥样硬化的独立危险因素。 Objective To explore the influential factors of carotid arteries(CA) atheromatous plaques and Intima-media thickness(IMT) in patients with chronic kidney disease(CKD).Methods A retrospective study was conducted on data of 217 CKD patients in stage 1-4 and the influential factors of IMT and CA atheromatous plaques were then analyzed.Results Univariate correlation analysis showed that IMT thickness was positively correlated with age,SBP,fibrinogen(FIB),fasting blood glucose(FBG),blood uric acid(BUA),serum phosphorus(SP),but negatively with glomerular filtration rate(GFR).CA atheromatous plaques was positively correlated with age,FIB,FBG,BUA,SP,but negatively with GFR.Multiple stepwise regression suggested that IMT was correlated with the gradings of CKD,BUA,FIB,age,SBP;atheromatous plaques with the gradings of CKD,FIB,age.Conclusion GFR,BUA,FIB,SBP,age are the independent risk factors of atherosclerosis in CKD patients.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第5期479-482,共4页 Chinese General Practice
关键词 慢性肾脏病 动脉粥样硬化 相关性 Chronic kidney disease Atherosclerosis Relationship
  • 相关文献

参考文献17

  • 1Govindarajan G, Saab G, Whaley - Connell A. Outcomes of carotid revascularization in patients with chronic kidney disease [ J]. Adv Chronic Kidney Dis, 2008, 15 (4) : 347 -354.
  • 2Essig M, Escoubet B, de Zuttere D, et al. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease [J]. Nephrol Dial Transplant, 2008, 23 (1): 239-248.
  • 3Sarnak M J, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease [ J ]. Circulation, 2003, 108: 2154-2169.
  • 4Nanayakkara PW, Kiefte - de - Jong JC, ter - Wee PM, et al. Randomized placebo - controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD [ J]. AmJKidnevDis, 2009, 53 (1): 41-50.
  • 5Shah DS, Polkinghome KR, Pellicano R, et al. Are traditional risk factors valid for assessing cardiovascular risk in end - stage renal failure patients? [J]. Nephrology, 2008, 13 (8): 667-671.
  • 6Mann JF, Gerstein HC, Dulau - FloreaI, et al. Cardiovascular risk in patients with mild renal insufficiency [ J ]. Kidney, 2003, ( Suppl 84) : S192-S196.
  • 7Bax L, Algra A, Mali WP, et al. Renal function as a risk indicator for cardiovascular events in 3216 patients with manifest arterial disease [J]. Atherosclerosis, 2008, 200 (1) : 184 -190.
  • 8Nasiek M, Kos - Kudla B, Ostrowska Z, et al. Acute phase proteins : C - reactive protein and fibrinogen in young women with polycystic ovary syndrome [J]. Pathophysiology, 2007, 14: 23-28.
  • 9Sun Y, lin CH, Lu C J, et al. Carotid atherosclerosis, intima media thickness and risk factors -an analysis of 1781 asymptomatic subjects in Taiwan [ J]. Atherosclerosis, 2002, 164 : 89 - 94.
  • 10Fang J, Alderman MH. Serum uric acid and cardiovascular mortalit) the NHANES I epidemiologic follow - up study, 1971 - 1992. National Health and Nutrition Examination Survey [ J ]. JAMA, 2000, 283 : 2404 - 2410.

同被引文献17

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部